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Indirect and direct routes 
to C-glycosylated flavones in Saccharomyces 
cerevisiae
Katherina Garcia Vanegas1, Arésu Bondrup Larsen2, Michael Eichenberger2, David Fischer2, 
Uffe Hasbro Mortensen1 and Michael Naesby2* 
Abstract 
Background: C-glycosylated flavones have recently attracted increased attention due to their possible benefits in 
human health. These biologically active compounds are part of the human diet, and the C-linkage makes them more 
resistant to hydrolysis and degradation than O-glycosides. In contrast to O-glycosyltransferases, few C-glycosyltrans-
ferases (CGTs) have so far been characterized. Two different biosynthetic routes for C-glycosylated flavones have been 
identified in plants. Depending on the type of C-glycosyltransferase, flavones can be glycosylated either directly or 
indirectly via C-glycosylation of a 2-hydroxyflavanone intermediate formed by a flavanone 2-hydroxylase (F2H).
Results: In this study, we reconstructed the pathways in the yeast Saccharomyces cerevisiae, to produce some rel-
evant CGT substrates, either the flavanones naringenin and eriodictyol or the flavones apigenin and luteolin. We then 
demonstrated two-step indirect glycosylation using combinations of F2H and CGT, to convert 2-hydroxyflavanone 
intermediates into the 6C-glucoside flavones isovitexin and isoorientin, and the 8C-glucoside flavones vitexin and 
orientin. Furthermore, we established direct glycosylation of flavones using the recently identified GtUF6CGT1 from 
Gentiana triflora. The ratio between 6C and 8C glycosylation depended on the CGT used. The indirect route resulted 
in mixtures, similar to what has been reported for in vitro experiments. In this case, hydroxylation at the flavonoid 
3′-position shifted the ratio towards the 8C-glucosylated orientin. The direct flavone glycosylation by GtUF6CGT1, on 
the other hand, resulted exclusively in 6C-glucosides.
Conclusions: The current study features yeast as a promising host for production of flavone C-glycosides, and it pro-
vides a set of tools and strains for identifying and studying CGTs and their mechanisms of C-glycosylation.
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Background
Flavones constitute a subclass of flavonoids, found in 
fruits and vegetables [1], which has been associated with 
a range of human health-related benefits [2]. The basic 
flavone scaffold comprises a three ring-skeleton (Fig. 1a) 
with three functional groups: a C4 ketone, a conjugated 
C2–C3 double bond and, depending on the flavone, 
various numbers of hydroxyl groups [2, 3]. In plants the 
flavonoid scaffold is synthesized by condensation of two 
precursors derived from two different pathways of the 
primary metabolism, p-coumaroyl-CoA from the phe-
nylalanine pathway and malonyl-CoA, an intermediate 
of fatty acid biosynthesis, to yield the common flavanone 
precursor naringenin [2, 4] (Additional file 1: Figure S1). 
Flavones are normally derived from the flavanones by the 
action of flavone synthase type I (FNS I), a 2-oxoglutar-
ate dependent dioxygenase [5], or type II (FNS II) [6], a 
cytochrome P450 oxidase (CYP450) which introduce a 
C2–C3 double bond in the heterocyclic C-ring (Fig. 1b).
Various modifications of the flavone backbone result in 
a high degree of chemical diversity, resulting in different 
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biological activities [2, 7]. One of the most common 
modifications is glycosylation, which can improve the 
biological activity and the solubility of the flavone [8, 9]. 
There are two main types of glycosylation, O-glycosyla-
tion and C-glycosylation, and the linkage of the glycosyl 
moiety to the flavone scaffold determines which type it 
is [10]. In C-glycosylation the linkage occurs directly 
between the glycosyl moiety and one of the carbon atoms 
of the flavone backbone [2]. C-glycosylation results in 
very stable molecules because the C–C bond linkage, 
b
a
Fig. 1 a Structures of some important flavones. b Predicted biosynthesis for C-glycosylated flavones from the common naringenin precursor. FNSI/
II, flavone synthase 1 or 2; F2H, flavanone-2-hydroxylase; F3′H, flavanone-3′-hydroxylase CGT, C-glycosyltransferase. Broken line arrows represent 
hypothetical steps not demonstrated in this study. Equilibrium arrows indicate 2-hydroxylflavanones equilibrium with its open-circular form. Light 
grey arrows indicate the indirect C-glycosylation pathway and dark grey arrows shows the direct C-glycosylation pathway
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unlike the O–C bond, is very resistant to acid hydroly-
sis and enzymatic glycosidase action [11, 12]. This has 
spurred an increased interest in C-glycosides for human 
health applications, including those related to metabolic 
syndrome [13, 14], since these molecules are expected to 
be more resistant to degradation in the human gastro-
intestinal system, and therefore more orally bioavailable. 
In addition, these compounds are being investigated for 
prevention of certain cancers [15, 16].
C-glycosylated flavones are widespread in nature, and 
natural sources include cereals like rice, wheat, and maize 
where these glucosides are among the most abundant 
flavonoids [11, 17, 18]. Additional sources of a variety of 
flavone C-glycosides are for example bamboo [19], buck-
wheat [20], and flax [21]. The most commonly found 
C-glycosides are the mono-glucosides vitexin, isovitexin, 
orientin, and isoorientin derived from the common pre-
cursor naringenin (Fig. 1b).
The biosynthesis of flavone C-glycosides was studied 
in cereals, and somewhat surprisingly it was found that 
flavones themselves are not the direct substrate of C-gly-
cosylation [11, 20, 22]. Instead, the substrate was shown 
to be the 2-hydroxyflavanone intermediate formed by a 
class of FNS II related flavanone 2-hydroxylases, belong-
ing to the CYP93 family of enzymes [23]. Glycosylation is 
proposed to happen on an open form of the 2-hydroxy-
flavanone and a dehydratase has been implied to catalyse 
the leaving of the 2-hydroxy group [11, 20, 23].
Other natural sources of flavone C-glucosides are 
dicots like the gentians [24] and passion fruit [25], which 
contain high amounts of isoorientin. Very recently, Sasaki 
and co-workers identified a C-glycosyltransferase from 
Gentiana triflora which catalyses the direct C-glycosyla-
tion of flavones, including apigenin and luteolin [26]. 
No other enzyme has so far been reported to do this 
reaction.
Despite the potential human benefits of flavone C-glu-
cosides, there are currently few reports of industrial scale 
production of these molecules from natural sources. 
This probably stems from the classical challenge of plant 
raw materials containing the desired compounds in low 
amounts and as part of complex mixtures. In turn, that 
would make production in an engineered, ferment-
able host an attractive alternative but there are so far no 
reports of de novo production of flavone C-glycosides 
in bacteria or yeast. Brazier-Hicks and Edwards co-
expressed the OsF2H (CYP93G2) and the OsCGT from 
rice (Oryza sativa) in yeast, and by feeding naringenin 
to the culture they showed production of 8.2  mg/L of 
the 2-hydroxynaringenin glucoside, which was chemi-
cally converted to the corresponding flavone C-glyco-
sides [27]. In contrast, production in yeast of naringenin 
from glucose has previously been reported [4, 28, 29] 
and the current study reports the reconstruction of full-
length pathways to the four basic C-glucosides isovitexin, 
vitexin, isoorientin and orientin.
Methods
Chemicals
Chemical standards for detection and quantification of 
phloretic acid, p-coumaric acid, naringenin, luteolin, 
apigenin, vitexin, isovitexin, orientin, isoorientin and 
eriodictyol, were purchased from Sigma-Aldrich (St. 
Louis, Missouri, USA). We acquired standards for all the 
expected compounds (see Fig.  1 for details), except for 
the two 2-hydroxyflavanones, 2-hydroxynaringenin and 
2-hydroxyeriodictyol. Neither of the two 2-hydroxy com-
pounds was available for purchase from reliable suppliers 
and were anyway expected to be unstable due to sponta-
neous conversion into flavones by dehydration [22, 30].
Strains and culture conditions
Escherichia coli (E. coli) XL10 Gold (Agilent, Santa Clara, 
California, USA) competent cells were used for sub-
cloning of genes. After transformation E. coli cells were 
cultured at 37 °C for 12 h on Luria Broth (LB) plates pre-
pared with 25 g/L of LB Broth with agar (Miller) and sup-
plemented with 100  μg/mL ampicillin. Plasmid rescue 
cultivations were prepared using liquid LB media pre-
pared with 25  g/L LB Broth (Miller) and supplemented 
with 100 μg/mL ampicillin.
Yeast strains used in this study were all direct descend-
ants of S. cerevisiae S288C strain NCYC 3608 (NCYC, 
Norwich, United Kingdom). One descendant, the BG 
strain described earlier [31], was the basis of strains 
used in this study (Table  1). The BG strain was modi-
fied to replace the non-functional gal2 gene with a 
functional allele from S. cerevisiae SK1 strain NCYC 
3615 (NCYC). Further, the ARO3 gene was deleted and 
replaced by mutant ARO4 and ARO7 genes, encoding 
de-regulated versions of these enzymes [32] resulting in 
strain EYS4988. To prevent degradation of precursors 
of the heterologous flavonoid pathway, the host genes 
ARO10, PAD1, and FDC1 were all deleted to create strain 
EVST27089 (Additional file  1: Figure S2). Finally, the 
entire naringenin pathway was integrated into the XI-3 
site [33] by in  vivo homologous recombination essen-
tially as described by Shao et  al. [34] to create strain 
EVST28856. This strain was used to express the flavone 
glucoside pathways on Homologous Recombination 
Technology (HRT) plasmids [31] (see plasmid assembly 
below). A list of genes used in this study is provided in 
Additional file 1: Table S1.
Yeast cultures were grown in Synthetic Complete (SC) 
Drop Out medium (Formedium, Hunstanton, United 
Kingdom) prepared with 47 g/L SC,-His,-Leu,-Ura Drop 
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Out powder. Depending on auxotrophic selection mark-
ers, the SC medium was supplemented with histidine 
(76 mg/L), leucine (380 mg/L), and/or uracil (76 mg/L). 
The pH was adjusted to 5.8 with hydrochloric acid, 
and the medium was then supplemented with 6.7  g/L 
yeast nitrogen base without amino acids (ThermoFis-
cher, Waltham, MA, USA) and 20  g/L d-(+)-glucose. 
For preparing plates, 20 g/L of agar was added. Cultures 
were grown in half-deep 96-well plates in a Kühner ISF-
1-W shaker (Kühner, Birsfelden, Switzerland) at 30  °C, 
300 RPM and 50 mm amplitude. Cultures were prepared 
by diluting a pre-culture to an optical density at 600 nm 
(OD600) of 0.1, and grown, in a final volume of 300 µL, 
at 30 °C, 300 RPM, and 50 mm amplitude for 72 h before 
being extracted and analysed.
Assembly of plasmids by in vivo homologous 
recombination
Sequences of selected genes (Additional file 1: Table S1) 
were codon optimized for expression in S. cerevisiae and 
synthesized by GeneArt (ThermoFisher). During synthe-
sis, all genes were provided with a HindIII restriction site 
and an AAA Kozak sequence at the 5′-end and a SacII 
restriction site at the 3′-end. These sites were used for 
cloning into yeast expression cassettes of HRT vectors 
pEVE2176, pEVE2177 or pEVE2178 for multigene plas-
mid assembly by in  vivo homologous recombination as 
described earlier [31]. Additional file  1: Figure S3 gives 
a schematic representation of the HRT technology and 
Additional file 1: Table S2 provides a detailed description 
of all plasmids used in this study. Briefly, the HRT vectors 
contained 60 bp recombination tags flanking the expres-
sion cassettes (promoter and terminator) into which the 
genes, or in some cases non-coding stuffer fragments, 
were cloned. The tagged cassettes were nested between a 
set of AscI restriction sites, used to release them from the 
vector backbone. Plasmids containing the expression cas-
settes, as well as helper fragments containing all elements 
required for single copy plasmid replication (pEVE1968) 
and selection (pEVE4730 or pEVE4729), and a closing 
linker (pEVE1973 or pEVE1916), were combined and 
digested with AscI in a single 10  μL reaction and used 
directly to transform yeast in a standard Li Acetate 
transformation [35]. Subsequently, the overlapping HRT 
recombination tags, flanking each fragment, directed the 
in vivo plasmid self-assembly.
Sample preparation and analytical method
After 72  h of cultivation, 150  μL of culture broth was 
transferred into a deep 96-well plate and diluted with 
1 volume 100% methanol. The diluted broth was incu-
bated for 10  min at 30  °C, 300  RPM, 50  mm amplitude 
and clarified by centrifugation for 5  min at 4000g. The 
cleared lysate was diluted 20 times in 50% methanol 
in water, transferred into  FrameStar® 96 Well Skirted 
Plates  (4titude®, Surrey, United Kingdom), and analysed 
by UPLC–MS on a Waters Acquity system coupled to 
a Waters Xevo G2 XS Tof mass detector (Milford, MA, 
USA). The system was equipped with a Waters Acquity 
 UPLC® BEH C18 column (1.7 µm, 2.1 mm × 50 mm) and 
the column temperature was kept at 55 °C. The gradient 
was composed of the two phases, water (A) and acetoni-
trile (B), both buffered with 0.1% formic acid. Initially, the 
B phase was kept constant at 10% for 0.1 min, and then 
the B fraction was increased from 10 to 25% over 2.4 min, 
and from 25 to 100% in 0.5 min. Finally, we performed a 
column wash procedure for 0.5 min with 100% phase B 
followed by equilibration in 10% B for 0.5 min. The flow 
rate was kept at 0.8 mL/min during the complete gradi-
ent program.
The mass analyser was set to operate in negative ion 
mode. The nebulization gas flow was set to 1000 L/h at 
a temperature of 500  °C. The cone gas flow was set to 
100  L/h and the source temperature was set to 150  °C. 
The capillary voltage and cone voltage were set to 1000 
and 40  V, respectively. For each compound of inter-
est we calculated peak areas on the extracted ion chro-
matograms of the respective [M–H]− ions using a mass 
window of 0.02 Da. Compounds were quantified using a 
Table 1 Main yeast strains used in this work
Strains Genotype Source
BG MATα his3Δ0 leu2Δ0 ura3Δ0 hoΔ0 gal2Δ0::GAL2 cat5Δ0::CAT5(J91 M) mip1Δ0::MIP1(A661T) sal1Δ0::SAL1(G403L) [31]
EYS4988 MATα his3Δ0 leu2Δ0 ura3Δ0 hoΔ0 gal2Δ0::GAL2 cat5Δ0::CAT5(J91 M) mip1Δ0::MIP1(A661T) sal1Δ0::SAL1(G403L) aro3Δ::LoxP/pTEF1-
ARO4(K229L)-tCYC1/pPGK1-ARO7(T266L)-tADH1
This study
EVST27089 MATα his3Δ0 leu2Δ0 ura3Δ0 hoΔ0 gal2Δ0::GAL2 cat5Δ0::CAT5(J91 M) mip1Δ0::MIP1(A661T) sal1Δ0::SAL1(G403L) aro3Δ::LoxP/pTEF1-
ARO4(K229L)-tCYC1/pPGK1-ARO7(T266L)-tADH1 aro10Δ::LoxP pad1Δ/fdc1Δ::LoxP
This study
EVST28856 MATα his3Δ0 leu2Δ0 ura3Δ0 hoΔ0 gal2Δ0::GAL2 cat5Δ0::CAT5(J91M) mip1Δ0::MIP1(A661T) sal1Δ0::SAL1(G403L) aro3Δ::LoxP/pTEF1-
ARO4(K229L)-tCYC1/pPGK1-ARO7(T266L)-tADH1 aro10Δ::LoxP pad1Δ/fdc1Δ::LoxP XI-3::loxP/pGPD1-MdCHSc_co-tCYC1/pPGK1-
MsCHI_co-tADH2/pTEF1-At4CL2_co-tENO2/pPDC1-AtPAL2_co-tFBA1/pTEF2-AmC4H_co-tPGI1/pPYK1-ScCPR-tADH1
This study
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linear calibration curve with authentic standards ranging 
from 0.03 to 4 mg/L for all compounds.
Results
Construction of yeast strains for flavanone and flavone 
production
In order to test C-glycosylation of both flavanones and 
flavones we created the four strains NAR1, ERI1, API1, 
and LUT1 producing the flavanones naringenin and 
eriodictyol, and the corresponding flavones apigenin 
and luteolin, respectively. The NAR1 strain was based 
on the EVST28856 strain, which already had the narin-
genin pathway, comprising the genes AtPAL2, AmC4H, 
ScCPR1, At4C2L, MsCHI, and MdCHS, integrated 
(Additional file 1: Figure S1). This strain had been fur-
ther optimized for aromatic amino acid production, 
by incorporating feedback insensitive versions of the 
native ARO4 and ARO7 genes [32]. To prevent degra-
dation of pathway precursors, the host genes ARO10, 
PAD1, and FDC1 had been deleted [4, 36] (Additional 
file 1: Figure S2).
The NAR1 strain was created by in  vivo assembly of 
a low-copy HRT vector comprising the AtCPR1 gene. 
Specifically, the cassettes for construction of the HRT 
plasmid were assembled in the following order (see Addi-
tional file  1: Figure S3 and Table  S2): a URA3 marker 
cassette for selection (from pEVE4730), an ARS4/CEN6 
cassette (from pEVE1968), two non-coding “stuffer 
sequence” cassettes (from pEVE2176 to pEVE27453), 
the AtCPR1 gene (from pEVE4012) cassette, and finally 
the EZ closing linker (from pEVE1916), which is used to 
close the plasmid as it fuses to pEVE4012 and pEVE4730 
(Additional file  1: Figure S3). The HRT plasmids in the 
ERI1, API1, and LUT1 strains were constructed in the 
same manner as NAR1 except that the relevant genes 
AmFNSII (pEVE23312) [37] and PhF3′H (pEVE3999) 
[38] substituted the empty cassettes. Hence, for the API1 
strain (containing AtCPR1 and AmFNSII) pEVE2176 
was replaced by pEVE23312. For the ERI1 strain (con-
taining AtCPR1 and PhF3′H) pEVE27453 was replaced 
by pEVE3999. For the LUT1 strain (containing AtCPR1, 
AmFNSII, and PhF3′H), pEVE2176 and pEVE27453 were 
replaced by pEVE23312 and pEVE3999, respectively. The 
four strains were cultured for 72 h and analysed for pro-
duction of the expected flavonoids.
The NAR1 strain produced 124.91 ± 6.94  mg/L narin-
genin, the ERI1 strain produced 133.43 ± 1.63 mg/L erio-
dictyol, and the API1 strain produced 80.74 ± 11.38 mg/L 
apigenin (Fig.  2). The LUT1 strain produced 
47.90 ± 6.05 mg/L luteolin, as well as around 25 mg/L of 
apigenin (Fig.  2). All four strains accumulated residual 
p-coumaric acid, between 18 and 19 mg/L in the NAR1 
and ERI1 strains, and 12–13  mg/L in API1 and LUT1 
strains, but no other direct intermediates were detected.
The four basic strains developed in this section, thus, 
set the stage for testing C-glycosylation of flavones, 
strains NAR1 and ERI1 by the indirect route and strains 
API1 and LUT1 by the direct route.
Indirect C‑glycosylation of flavones 
via 2‑hydroxyflavanones
In some monocots such as the cereals rice, sorghum, 
and maize, C-glycosylated flavones are the major class 
of flavonoids [11], and recent work has shown that these 
flavones are derived from 2-hydroxylated flavanones. 
Furthermore, in these plants, CYP450 enzymes have 
been shown to hydroxylate flavanones at the 2-position, 
and the 2-hydroxyflavanones then serve as substrate for 
the C-glycosyltransferases. Three flavanone 2-hydroxy-
lases including the rice (Oryza sativa) OsCYP93G2 [23], 
the sorghum (Sorghum bicolor) SbCYP93G3 [39], and the 
maize (Zea mays) ZmCYP93G5 [40] were selected for 
providing 2-hydroxylated flavanones for C-glycosylation.
Although CGTs have been identified from the mono-
cots rice and maize, the latter of these has been reported 
to also show O-glycosylating activity on 2-hydroxy-
lated flavanones [12]. However, also dicots are known 
to produce flavone C-glycosides, both of the 6C and 8C 
types, and it seems that plants acquired the ability to 
C-glycosylate 2-hydroxyflavanones before the mono-
cot–dicot species split [22]. Hence, CGTs would be 
expected to accept 2-hydroxyflavanones independent on 
which F2H, dicot or monocot, provides them. Thus, two 
dicot CGTs, the UGT708C2 [20] from buckwheat (Fag-
opyrum esculentum) and the UGT708D1 [22] from soy-
bean (Glycine max), with no reported O-glycosylation 
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Fig. 2 Basic strains for testing both indirect and direct 
C-glycosylation pathways. Production of naringenin (white), 
eriodictyol (dark grey), apigenin (light grey), and luteolin (black) by 
strains NAR1, ERI1, API1 and LUT1, respectively. Represented are 
averages and standard deviations of four independent cultures
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activity, were chosen for producing the four correspond-
ing C-glycosides from either 2-hydroxynaringenin or 
2-hydroxyeriodictyol.
By in  vivo assembly of a second HRT plasmid, com-
binations of F2H and CGTs were introduced into strain 
NAR1 to create a set of strains NCG1–NCG6, and into 
strain ERI1 to create a set of strains ECG1–ECG6 (see 
Table  2). For the second HRT plasmid a different back-
bone was used (pEVE4729) to allow co-selection with 
the first plasmid, using a different selectable marker (see 
Additional file  1: Table  S2). Further, it comprised one 
empty cassette (pEVE2178). These 12 new strains were 
cultured and analysed for production of flavone C-gluco-
sides (Fig. 3).
NCG strains were analysed for naringenin and the 
corresponding C-glucosides isovitexin (apigenin-
6C-glucoside) and vitexin (apigenin-8C-glucoside) 
(Fig.  3a and Additional file  1: Figure S4). As we 
expected the 2-hydroxynaringenin intermediate to be 
potentially unstable, the strains were also analysed for 
the aglycone apigenin. All strains accumulated very lit-
tle naringenin, less than 2.3 mg/L, and relatively small 
amounts of apigenin, less than 20.5 mg/L. In contrast, 
they all produced large quantities of both isovitexin 
and vitexin. Although not statistically significant, the 
trend was towards slightly more of the 6C glucoside 
isovitexin. With all three F2H enzymes the UGT708C2 
gave the highest titres, reaching around 140 mg/L iso-
vitexin and around 125 mg/L of vitexin in combination 
with either OsCYP93G2 (strain NCG1) or SbCYP93G3 
(strain NCG3).
ECG strains were similarly analysed for eriodictyol 
and the corresponding C-glucosides isoorientin (luteo-
lin-6C-glucoside) and orientin (luteolin-8C-glucoside), 
as well as other potential intermediates of this pathway. 
As seen in Fig. 3b, these strains accumulated relatively 
high amounts of non-reacted eriodictyol, up to around 
30  mg/L, and some non-glycosylated luteolin, up to 
about 13 mg/L. Surprisingly, all ECG strains exhibited a 
clear preference for producing the 8C-glycosylated ori-
entin versus the 6C-glycosylated isoorientin. In strain 
ECG2, for example, a level of 67.03 ± 2.92  mg/L ori-
entin was reached, compared to 29.19 ± 0.24  mg/L of 
isoorientin.
The ECG strains also accumulated products derived 
from naringenin via 2-hydroxynaringenin, i.e. more 
than approx. 50  mg/L isovitexin and 48  mg/L vitexin 
(Additional file 1: Table S3). This reflects the competi-
tion between two branches of the biosynthetic path-
way, in which F2H and F3′H compete for the common 
substrate naringenin, leading to formation of either 
2-hydroxynaringenin or, via eriodictyol, to 2-hydroxye-
riodictyol, with both 2-hydroxylated compounds being 
substrates for the CGTs (see Fig. 1).
In all the NCG and ECG strains additional peaks were 
detected (Additional file 1: Table S4). Interestingly, the 
m/z value of two of these peaks corresponded to the 
Table 2 List of  the  two strain sets for  indirect production 
of C-glycosylated flavones
NCG strain set ECG strain set Gene combinations 
on corresponding HRT 
plasmid
NCG1 ECG1 OsCYP93G2 and UGT708C2
NCG2 ECG2 OsCYP93G2 and UGT708D1
NCG3 ECG3 SbCYP93G3 and UGT708C2
NCG4 ECG4 SbCYP93G3 and UGT708D1
NCG5 ECG5 ZmCYP93G5 and UGT708C2
NCG6 ECG6 ZmCYP93G5 and UGT708D1
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Fig. 3 Indirect C-glycosylation. a NCG strains production of naringenin (white), apigenin (light grey), isovitexin (grey hatching) and vitexin (black 
hatching). b ECG strains production of eriodictyol (dark grey), luteolin (black), isoorientin (grey checker) and orientin (black checker). Represented 
are averages and standard deviations of four independent cultures
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calculated mass of 2-hydroxyflavanone-C-glucosides 
and these peaks most likely represent the hypothesized 
intermediates for the C-glycosylated flavones. This 
notion is supported by the fact that NCG strains gave 
rise only to compounds predicted to derive from nar-
ingenin, whereas in the ECG strains peaks expected 
to derive from both naringenin and eriodictyol were 
detected. Unfortunately, these compounds could 
not be quantified due to lack of authentic reference 
compounds.
Direct C‑glycosylation of flavones by Gentiana triflora CGT 
Recently a CGT from G. triflora was characterized and 
shown to C-glycosylate flavones directly at the 6C-posi-
tion of both apigenin and luteolin [26]. This CGT, known 
as GtUF6CGT1, was cloned and expressed on a sec-
ond HRT plasmid in both the API1 and LUT1 strains. 
As above, the backbone used for the HRT plasmid 
(pEVE4729) was different from that of the first plasmid, 
and this time also a different closing linker was used 
(pEVE1973). The strains were named ACG1 and LCG1, 
respectively. An empty cassette (pEVE2176) was used 
instead of the CGT, to create the control strains API2 and 
LUT2. These four new strains were analysed for produc-
tion of flavones and their corresponding C-glycosides 
(Fig.  4, Additional file  1: Table  S5). When GtUF6CGT1 
was expressed in the ACG1 strain, we recorded produc-
tion of more than 200 mg/L (206.47 ± 2.92 mg/L) of the 
apigenin-6C-glucoside isovitexin, and almost none of the 
8C-glucoside vitexin. In the LCG1 strain we observed 
a similar preference for the 6C-position, and detected 
both isovitexin (apigenin-6C-glucoside) and isoori-
entin (luteolin-6C-glucoside) of more than 60  mg/L 
(64.24 ± 0.51  mg/L) and 30  mg/L (31.47 ± 0.38  mg/L), 
respectively. Less than 4  mg/L of orientin was detected 
and essentially no vitexin. More than 63 mg/L of luteo-
lin, and close to 6 mg/l apigenin accumulated in the cul-
ture broth (Additional file1: Table S5). These high levels 
of apigenin and isovitexin obviously reflects an insuf-
ficient F3′H activity in the biosynthetic pathway, some-
thing that was evident already in the parent LUT1 strain, 
but which seems to be exacerbated by the addition of the 
CGT. The fact that almost all apigenin gets glycosylated, 
whereas more than two-thirds of luteolin remains non-
glycosylated, would indicate a preference by the glycosyl-
transferase for apigenin over luteolin, thereby creating an 
extra pull towards isovitexin. This is in contrast to what 
has been reported in  vitro, where the partially purified 
enzyme showed higher activity on luteolin compared 
to apigenin [26]. Sasaki and co-workers reported that 
GtUF6CGT1 accepts only apigenin and luteolin as sub-
strates, but not other flavonoids. In agreement, we found 
that NAR1 and ERI1 strains expressing the GtUF6CGT1, 
in the presence or absence of F2H, did not produce any 
detectable glycosylation products (data not shown).
Discussion
Production of flavanones and flavones
To provide the relevant substrates for production of 
flavone C-glycosides we constructed the four parental 
strains NAR1, ERI1, API1, and LUT1. The NAR1 strain 
produced around 125 mg/L naringenin, and in the ERI1 
strain this was efficiently hydroxylated at the 3′-position 
by PhF3′H. The conversion of naringenin to apigenin by 
AmFNSII was less efficient, and only around two-thirds 
of naringenin was oxidized to apigenin in the API1 strain. 
To improve this situation perhaps a more active FNS 
could be identified, or the copy number of AmFNSII 
could be increased. However, the fact that hardly any nar-
ingenin was left in the culture might suggest other issues, 
e.g. production of unstable intermediates or derail-
ment products. Similarly, the LUT1 strain produced less 
amount of flavone than expected and, again, this could 
be due to incomplete conversion by the FNS. Further, the 
relatively high residual level of apigenin would reflect a 
competition for naringenin between F3′H and FNS (see 
Fig.  1b), combined with the expected low or no affinity 
of F3′H for apigenin. In the flavonoid pathway it is gener-
ally assumed that F3′H acts only on flavanones and dihy-
droflavonols. It suggests that higher expression of F3′H 
might help shift the balance towards higher production 
of eriodictyol and, eventually, luteolin.
Production of flavone C‑glycosides
Several papers recently reported the biosynthe-
sis of flavone C-glucosides in a two-step process, in 
which the actual substrate of CGTs is the open form of 
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2-hydroxyflavanones, the product of F2H [11, 20, 23]. 
In vitro, the glycosylated molecule would then ring-close, 
with concomitant loss of the OH-group, to form a mix of 
6C- and 8C-glyccosides. The analysis of these products 
is challenging, since under many LC-MS conditions they 
will run as a single peak with the same mass. When even-
tually separated, they mostly show an approx. 1:1 ratio of 
the two glycosides [20, 22]. However, this ratio between 6C 
and 8C likely reflects only the in vitro situation, and it has 
been suggested that in planta the dehydration is an enzy-
matic process, involving a dehydratase, which directs the 
preferential formation of one isomer over the other. Bra-
zier-Hicks and co-workers reported that incubating the 
rice OsCGT with the substrate 2,5,7-trihydroxyflavanone 
produced the corresponding 2,5,7-hydroxyflavanone-
C-glucoside, which would spontaneously decompose to 
the 6C and 8C glucosides in the ratio of 0.5:1. In contrast, 
with a crude protein extract from rice cell cultures the for-
mation of the 6C-glucoside would increase over time. They 
concluded that this was due to an enzymatic dehydratase 
activity [11]. Nagatomo and co-workers reported that 
incubating a recombinant UGT708C1 with 2-hydroxynar-
ingenin resulted in a 6C:8C ratio of 1.37:1 in acid treated 
extracts, compared to a ratio of 1.87:1 in extracts from 
buckwheat cotyledons [20]. They concluded that this dif-
ference could only be explained by an enzymatic activity 
in the plant. Despite these results, a specific dehydratase 
enzyme has still to be identified and characterized.
Here, when F2Hs and CGTs were combined in the 
NAR1 strain we observed a good conversion into isovi-
texin and vitexin with a slight preference for isovitexin. 
These results are in line with in vitro results and, hence, 
indicates that there is no native dehydratase activity 
in yeast. Rather, the dehydration is likely spontaneous 
and driven by the acidification of the growth medium 
to which the 2-hydroxynaringenin-glucoside is readily 
secreted [27]. Additionally, small amounts of apigenin 
were detected, which could be due to residual FNS activ-
ity of F2H or spontaneous dehydration of the 2-hydroxy-
group to form the C2–C3 double bond. We also detected 
2-hydroxynaringenin and its glycoside 2-hydroxynar-
ingenin-glucoside, but these compounds could not be 
quantified due to lack of standards (Additional file  1: 
Table  S4). However, the detection of these compounds 
indicates some stability of the 2-OH group, in particular 
after glycosylation. Similar results were reported earlier, 
where yeast co-expressing F2H and CGT, and being fed 
with naringenin, produced predominantly 2-hydroxy-
naringenin glucoside, which accumulated in the growth 
medium [27]. However, as seen in  vitro [11, 23], we 
would expect the eventual spontaneous dehydration of 
these compounds due to the gradual acidification of the 
medium, which after 72 h was around pH 3–4.
When the ERI1 strain was used for expressing combi-
nations of F2Hs and CGTs the production of isovitexin 
and vitexin exhibited the same ratio between 6C and 8C 
glycosylation as seen in all the NCG strains (Additional 
file  1: Table  S3). These glucosides were derived from 
residual naringenin, before this could be hydroxylated 
to eriodictyol. However, when eriodictyol was the direct 
substrate, the combined expression of F2H and CGT pro-
duced the 6C-glycosylated isoorientin and the 8C-glyco-
sylated orientin in the ratio of approx. 1:2 as measured 
in the growth medium. Roughly the same ratio was seen 
for both of the two CGTs and, assuming the absence of 
enzymatic dehydratase activity, would suggest a pro-
pensity of the free, open conformation of 2-hydroxye-
riodictyol to ring-close with the glucose attached at the 
8C-position. We speculate that this conformation would 
be preferred due to some slightly stabilizing interactions, 
e.g. hydrogen bonding between the 3′-hydroxy group and 
the 6C-hydroxy group of the glucose, during ring closure. 
Also in all the ECG strains we detected compounds with 
the predicted mass of 2-hydroxyeriodictyol and its glu-
coside, as well as the corresponding derivatives of nar-
ingenin (Additional file  1: Table  S4). As with the NCG 
strains, we detected residual amounts of flavones, specifi-
cally luteolin.
In contrast to the indirect 2-step C-glycosylation, 
expression of GtUF6CGT1 in strains ACG1 and LCG1 
resulted almost exclusively in the 6C-glycosides of these 
flavones (Fig. 4). This is similar to what was reported by 
Sasaki and co-workers [26], and was therefore expected. 
We confirmed that in yeast, this enzyme retains its speci-
ficity for flavones, and does not accept flavanones. By 
further increasing the CGT activity in the ACG1 strain, 
we believe it should be possible to convert the remain-
ing flavone to obtain an even higher amount of pure 
isovitexin. In addition, production of pure isoorientin 
should be achievable with this CGT, although some chal-
lenges remains. Firstly, the production of apigenin, and 
its C-glucosides, must be prevented by improving the 
flux towards eriodictyol. And secondly, the glycosylation 
of luteolin must be improved, e.g. by further overexpres-
sion of GtUF6CGT1 or by optimizing media and culture 
condition which may improve the specific activity of this 
enzyme. In any case, further progress would involve bal-
ancing the flux of the entire biosynthetic pathway.
Conclusions
The yeast S. cerevisiae is an attractive production host for 
plant secondary metabolites due to its ability to efficiently 
express most plant genes, including CYP450s, its amena-
bility to metabolic engineering, and the extensive indus-
trial experience acquired regarding its fermentation and 
downstream processing. In the current study, we show 
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that S. cerevisiae can also be used as an efficient platform 
for the identification of C-glycosyltransferases. Consid-
ering the industrial potential of S. cerevisiae, we believe 
that this yeast would make an excellent host for produc-
tion of commercially relevant flavone C-glycosides.
Based on previous results and those presented here, 
it would seem relatively straightforward to establish 
isovitexin production by fermentation of yeast, using 
the 6C-specificity of GtUF6CGT1. More specific pro-
duction of isoorientin could possibly be achieved by 
various engineering solutions, such as channelling the 
substrate via enzyme fusions, or by spatiotemporal sep-
aration of the required enzymatic steps. Alternatively, 
more specific enzymes could possibly be identified and/
or engineered. The current strains provide an ideal set-
up to allow screening for the desired activity.
Production of the 8C-glycosides looks more chal-
lenging. Perhaps a homolog of GtUF6CGT1, with the 
opposite specificity can be found. Unfortunately, no 
close homologs of the GtUF6CGT1 have so far been 
reported, nor are there any obvious candidates in public 
sequence databases. Alternatively, the two-step path-
way would have to be improved. That, in turn, would 
likely involve further studies on the ring-closure mech-
anism, and/or identification of the elusive dehydratase. 
Also for such studies, the strains presented here would 
be useful, either as a screening tool or for more detailed 
studies of the C-glycosylation mechanisms.
Clearly, the current proof of concept study provides 
only the first step towards commercial production 
of these compounds, and huge efforts will have to go 
into both fermentation scale-up and downstream pro-
cess development before this is a reality. However, we 
believe that researchers and engineers will eventually 
be able to fully control the biosynthetic pathway leading 
to specific flavone C-glycosides, allowing cost efficient 
production of any desired molecule. This will provide 
the pure compounds needed to study their potential 
health benefits, as well as afford the basis for poten-
tial commercial applications e.g. as nutritional supple-
ments or functional ingredients in processed foods and 
beverages.
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